786O Tumor biomarker analysis from COLUMBUS part 1: Encorafenib + binimetinib for BRAF V600E/K-mutant advanced or metastatic melanoma

Authors :: R. Dummer
N. Pathan
S. Deng
C. Robert
A.M. Arance Fernandez
J.W.B. de Groot
C. Garbe
H.J. Gogas
R. Gutzmer
I. Krajsova
G. Liszkay
C. Loquai
M. Mandala
D. Schadendorf
N. Yamazaki
A. di Pietro
T. Xie
P.A. Ascierto
K. Flaherty
Source :: Annals of Oncology. 33:S902
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools